Potential biomarkers for cardiovascular and kidney disease in lupus:
Potential biomarkers for neuropsychiatric disease in lupus:
Research shows that ALCAM is a leading biomarker for Lupus Nephritis and a Therapeutic Target:
As a member of the Medical and Scientific Advisory Board of the Lupus Foundation of America, Dr. Mohan presents a talk highlighting the unique aspects of Lupus in Men:
Dr. Mohan presents a seminar at the American College of Rheumatology Annual Meeting 2020, reviewing the major accomplishments in Lupus Research over the past decade:
February 21st: Nephropathologist Jan Becker visits Dr. Mohan’s laboratory to discuss neural network classification of lupus nephritis, together with other Houston area nephropathologists.
Pictured left to right: Dr. Mohan, Qiang, Crosslee, Pietro, and Dr. Becker
February 5-6th: Raji attended Flow Tex 2020: 13th Annual flowcytometry conference That was held at MD Anderson, Houston, TX.
December 15th: Most of the current Mohan group members attended the annual holiday party hosted at Dr. Mohan’s home! It was a great night filled with laughter, games, and fantastic food!
April 2nd: An article in UH news announcing $5 million in NIH grants has been awarded to Drs. Mohan and Wu, titled: Researchers Developing Early Detection, Home Monitoring Tests for Lupus Nephritis
February 28th: Lupus Research Alliance article discusses how the ALCAM pathway discovered by Dr. Moahn is the basis for a new clinical trial for treating lupus that has not responded to current interventions: LRA-funded Research Backs New Lupus Nephritis Clinical Trial
February 26th: Article outlining how Dr. Mohan will be involved in a Phase 1 clinical trial to develop a treatment for unresponsive Lupus: Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus Nephritis
February 10-14th: Dr. Rajalakshmy Ayilam Ramachandran presented her poster titled: ALCAM in lupus at the Keystone Symposia: B cell-T Interactions (J6) in Keystone, Colorado.
January 6th: Most of the Mohan group members attend a New Years’ party! We’re ready for another productive, successful year!
October 24-26th: We hosted our long-term collaborator, Ioannis Parodis, from the Karolinska Institutet in Sweden. We mixed detailed and insightful discussions about our research progress and goals into lupus with a little sightseeing around Houston. We look forward to seeing you again soon!
October 23rd: Sirisha Gokaraju presented her poster, “Urine VCAM-1 and ALCAM in SLE and lupus nephritis,” at the American College of Rheumatology annual conference in Chicago, IL. Ting Zhang also attended the conference.
August 20th: A recent grant from the Chron’s & Colitis Foundation of America is award to Dr. Mohan and is highlighted in UH news, titled: Stool Proteins to Predict Inflammatory Bowel Disease
July 31st: UH news article announcing Dr. Mohan has been awarded a $2 million grant from the NIH to investigate why more women than men suffer from Lupus: Women and Lupus – Tackling the Debilitating Connection
March 27th: Mohan Lab research is highlighted in Houston news: Houston research team on verge of painless lupus testing
February 20th: UH news reports on a $600,000 grant has been awarded to Dr. Mohan from the Lupus Research Alliance. UH Engineering News: Deconstructing Lupus – Could Some Of Its Makeup Be Part Of Its Cure?
February 10th: Sanam receives a travel grant and attends weSTEM 2018 in Champaign, IL. Congratulations!
November 11-16th: Mohan Lab research is featured in dddmag.com: Could a Saliva Test Be Next for Lupus? and Lupus News Today: A Saliva Test to Diagnose Lupus May Soon Become a Reality
November 4-8th: Kamala and Sanam attend and present at the American College of Rheumatology annual conference in San Diego, CA.